Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia

NCT03062631 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

OTHER

Sponsor class

Conditions

Congenital Myasthenic Syndrome

Interventions

DRUG: 3,4-Diaminopyridine

Sponsor

Ricardo Maselli

Collaborators

[object Object]